These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 26850693)
1. Betaine chemistry, roles, and potential use in liver disease. Day CR; Kempson SA Biochim Biophys Acta; 2016 Jun; 1860(6):1098-106. PubMed ID: 26850693 [TBL] [Abstract][Full Text] [Related]
2. Preventive and therapeutic role of betaine in liver disease: A review on molecular mechanisms. Wang C; Ma C; Gong L; Dai S; Li Y Eur J Pharmacol; 2021 Dec; 912():174604. PubMed ID: 34743980 [TBL] [Abstract][Full Text] [Related]
3. Betaine transport in kidney and liver: use of betaine in liver injury. Kempson SA; Vovor-Dassu K; Day C Cell Physiol Biochem; 2013; 32(7):32-40. PubMed ID: 24429813 [TBL] [Abstract][Full Text] [Related]
4. Alleviation of alcoholic liver injury by betaine involves an enhancement of antioxidant defense via regulation of sulfur amino acid metabolism. Jung YS; Kim SJ; Kwon DY; Ahn CW; Kim YS; Choi DW; Kim YC Food Chem Toxicol; 2013 Dec; 62():292-8. PubMed ID: 23994088 [TBL] [Abstract][Full Text] [Related]
5. Effects of betaine on non-alcoholic liver disease. Chen W; Xu M; Xu M; Wang Y; Zou Q; Xie S; Wang L Nutr Res Rev; 2022 Jun; 35(1):28-38. PubMed ID: 33818349 [TBL] [Abstract][Full Text] [Related]
7. How to prevent alcoholic liver disease. French SW Exp Mol Pathol; 2015 Apr; 98(2):304-7. PubMed ID: 25758202 [TBL] [Abstract][Full Text] [Related]
8. Betaine in human nutrition. Craig SA Am J Clin Nutr; 2004 Sep; 80(3):539-49. PubMed ID: 15321791 [TBL] [Abstract][Full Text] [Related]
9. Alleviation of acute ethanol-induced liver injury and impaired metabolomics of S-containing substances by betaine supplementation. Kim SJ; Jung YS; Kwon DY; Kim YC Biochem Biophys Res Commun; 2008 Apr; 368(4):893-8. PubMed ID: 18267108 [TBL] [Abstract][Full Text] [Related]
10. Potential nutritional and physiological functions of betaine in livestock. Eklund M; Bauer E; Wamatu J; Mosenthin R Nutr Res Rev; 2005 Jun; 18(1):31-48. PubMed ID: 19079893 [TBL] [Abstract][Full Text] [Related]
11. [Treatment of liver diseases, especially of fatty liver with betaine citrate]. Semmler F Ther Ggw; 1977 Nov; 116(11):2113-24. PubMed ID: 337559 [No Abstract] [Full Text] [Related]
12. The glycine betaine role in neurodegenerative, cardiovascular, hepatic, and renal diseases: Insights into disease and dysfunction networks. Rosas-Rodríguez JA; Valenzuela-Soto EM Life Sci; 2021 Nov; 285():119943. PubMed ID: 34516992 [TBL] [Abstract][Full Text] [Related]
13. Dimethylthetin treatment causes diffuse alveolar lung damage: a pilot study in a sheep model of Continuous Ambulatory Peritoneal Dialysis (CAPD). Slow S; Vasudevamurthy M; Fraser R; McEntyre C; Lever M; Chambers S; George P Exp Toxicol Pathol; 2007 Apr; 58(5):285-90. PubMed ID: 17175148 [TBL] [Abstract][Full Text] [Related]
14. Long-term betaine therapy in a murine model of cystathionine beta-synthase deficient homocystinuria: decreased efficacy over time reveals a significant threshold effect between elevated homocysteine and thrombotic risk. Maclean KN; Jiang H; Greiner LS; Allen RH; Stabler SP Mol Genet Metab; 2012 Mar; 105(3):395-403. PubMed ID: 22192524 [TBL] [Abstract][Full Text] [Related]
15. The betaine/GABA transporter and betaine: roles in brain, kidney, and liver. Kempson SA; Zhou Y; Danbolt NC Front Physiol; 2014; 5():159. PubMed ID: 24795654 [TBL] [Abstract][Full Text] [Related]
16. [Betaine aspartate in the hepato-digestive domain]. Cachin M; Pergola F Sem Ther; 1966 Oct; 42(8):423-4. PubMed ID: 5994378 [No Abstract] [Full Text] [Related]
17. Glutathione in the treatment of liver diseases: insights from clinical practice. Sacco R; Eggenhoffner R; Giacomelli L Minerva Gastroenterol Dietol; 2016 Dec; 62(4):316-324. PubMed ID: 27603810 [TBL] [Abstract][Full Text] [Related]
18. [Effect of a modified low protein and low fat diet on histologic changes and metabolism in kidneys in an experimental model of polycystic kidney disease]. Banković-Calić N; Ogbori MR; Nicman E Srp Arh Celok Lek; 2002; 130(7-8):251-7. PubMed ID: 12585002 [TBL] [Abstract][Full Text] [Related]
19. The clinical significance of betaine, an osmolyte with a key role in methyl group metabolism. Lever M; Slow S Clin Biochem; 2010 Jun; 43(9):732-44. PubMed ID: 20346934 [TBL] [Abstract][Full Text] [Related]
20. Betaine: a potential agent for the treatment of hepatopathy associated with short bowel syndrome. Teixeira Araújo G; Domenici F; Elias J; Vannucchi H Nutr Hosp; 2014 Jun; 29(6):1366-71. PubMed ID: 24972476 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]